Search

everythinglearnresearchcommunity

for

Search:↓

Severe hair loss significantly worsens quality of life.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

The vitamin D receptor helps regulate skin and hair health independently of its usual vitamin D ligand.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Genetic factors could lead to personalized treatments for hair loss.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Lower SHBG levels may increase the risk of PCOS.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Eating vegetarian, having allergies, and family history might be linked to getting gray hair early.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Regulating certain sex hormones may help delay facial aging.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.